12th Foundation Day Celebration of Indian Pharmacopoeia Commission
The Indian Pharmacopoeia Commission (IPC) celebrated its 12th Foundation Day on 01.01.2020 in the premises of IPC. IPC was established as an autonomous institution under the Ministry of Health & Family Welfare, Government of India on 1st January 2009. On this occasion emphasis was given on strengthening the quality, safety and efficacy of drugs in India by the dignitaries Mr Rajiv Wadhawan, Director Drugs, Ministry of Health and Family Welfare, Govt. of India and Dr. V. G. Somani, Drugs Controller General of India.
Dr Jai Prakash, Secretary-cum-Scientific Director (In-Charge) apprised about various activities and achievements of IPC since its creation. He informed that Indian Pharmacopoeia (IP)is published by the IPC on behalf of the Ministry of Health & Family Welfare, Government of India in fulfilment of the requirements of the Drugs and Cosmetics Act, 1940 and the Rules framed thereunder. On this occasion he highlighted various salient features of IP, National Formulary of India (NFI) and emphasized the need of its regular updatingto meet the essential requirements for harmonization of analytical methods in IP with those accepted internationally keeping in view Indian scenario.
He also explained about IP Reference Substances and their importance as a fingerprint criteria for ensuring identity, quality and strength of drugs. He also touched upon NFI updation, Pharmacovigilance Programme of India (PvPI), Materiovigilance Programme of India (MvPI), Training imparted to the healthcare professionals through Skill Development Programme and collaboration of IPC with various laboratories and academic institutions. He told that at present PvPI is having 270 ADR Monitoring Centres all over India.
Dr. Jai Prakash Secretary-cum-Scientific Director (I/c) welcoming Mr. Rajiv Wadhawan, Director (Drugs), MoHFW, Govt of India & Dr. V. G. Somani, DCG (I) on the occasion of 12th Foundation Day of IPC.
Launching of 10 system suitability impurities standards by Mr. Rajiv Wadhawan, Director (Drugs), MoHFW, Govt of India & Dr. V. G. Somani, DCG (I) on the occasion of 12th Foundation Day of IPC in presence of Secretary-cum-Scientific Director & IPC Scientists.
Mr. Rajiv Wadhawan, Director (Drugs), MoHFW, Govt of India & Dr. V. G. Somani, DCG (I) and Dr. Jai Prakash Secretary-cum-Scientific Director (I/c), along withIPC staff in Group Photograph on the occasion of 12th Foundation Day of IPC.
Mr Rajiv Wadhawan, Director Drugs Ministry of Health and Family Welfare, Govt. of India congratulated the IPC and the Expert Members of the Scientific Body for their contributions for achieving IPC mandates. He also congratulated IPC for the 1st time recognition of IP in Afghanistan. He also wished to extend similar recognition in African & Asian continent countries. He further said that IPC should present its activities at different forums to enhance its visibility. Shri Wadhawan visited all the divisions of IPC and discussed these in depth with IPC scientists. He discussed about Indian Pharmacopoeia and IP reference substance, its development and distribution network all over the country. He also discussed about the PvPI and suggested that more and more Adverse Drug Reactions Monitoring Centres should be connected with National Coordination Centre (NCC)-PvPI.
Dr V G Somani, said that IPC has done a great service to the society by setting the standards for drugs in the country. He appreciated the efforts of IPC for timely publication of the IP and emphasized that IPC should develop the latest technologies in its laboratory so that challenges in quality testing in India can be addressed. He emphasized that IPC should do the Gap analysis so that the drug standards can be developed which are actually required in India. 10 system suitability impurity standards were released by DCG (I) & Director (Drugs) on this occasion.
Professor. K. K. Sharma, Former Professor & Department of Pharmacology, University College of Medical Sciences, New Delhi appreciated the efforts of IPC for its work done quality regarding safety, efficacy of medicines & consumer reporting for adverse drug reactions in the country.
The programme ended with vote of thanks by Dr Kalaiselvan followed by round of the IPC laboratory by the dignitaries.